Form 8-K - Current report:
SEC Accession No. 0001193125-19-322441
Filing Date
2019-12-23
Accepted
2019-12-23 14:28:13
Documents
13
Period of Report
2019-12-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d118738d8k.htm   iXBRL 8-K 27980
2 EX-99.1 d118738dex991.htm EX-99.1 53150
  Complete submission text file 0001193125-19-322441.txt   196542

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20191223.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20191223_lab.xml EX-101.LAB 15302
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20191223_pre.xml EX-101.PRE 9637
12 EXTRACTED XBRL INSTANCE DOCUMENT d118738d8k_htm.xml XML 3088
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 191305142
SIC: 2835 In Vitro & In Vivo Diagnostic Substances